Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additive Effect of Brinzolamide/Brimonidine Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue
2015-000736-15Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of brinzolamide + brimonidine in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Mean change from baseline in diurnal intraocular pressure. Started Jul 2015; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2015-000736-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000736-15.